EYPT CIK: 1314102

EyePoint, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
28.8
FY22:
–
FY23:
41.4
FY24:
39.6
FY25:
29.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−63.5
FY22:
−99.6
FY23:
−79.7
FY24:
−150
FY25:
−246
(positive)
Change from FY21 to FY25
millions USD
FY21:
−52.2
FY22:
–
FY23:
−67.7
FY24:
−129
FY25:
−229
(positive)
Change from FY21 to FY25
millions USD
FY21:
−58.4
FY22:
−102
FY23:
−70.7
FY24:
−131
FY25:
−232
(positive)
Change from FY21 to FY25
millions USD
FY21:
−58.4
FY22:
−102
FY23:
−70.8
FY24:
−131
FY25:
−232

All amounts in millions USD Data sources:SEC EDGARTwelve Data